Optimizing CGM and CKM Data Across Populations, Interpretation, Integration, and Clinical Decision-Making

This activity was originally presented at the 2026 Diabetes Day of Education.

Program Description

While continuous glucose monitoring (CGM) has shifted the management of diabetes, the true clinical impact of CGM technology relies on a pharmacist’s ability to translate data into actionable therapeutic adjustments and the pharmacy technician’s ability to support people living with diabetes to ensure optimal use. In this collaborative panel discussion, experts will move beyond basic device features to focus on the high-level interpretation of ambulatory glucose profile reports with an illustrative discussion on how to efficiently identify patterns indicating concerns such as hyperglycemia or potentially dangerous nocturnal hypoglycemia episodes. Panelists will emphasize a holistic approach to patient care, exploring how pharmacists and pharmacy technicians can provide support and ensure long-term CGM persistence through streamlined data-sharing workflows and optimized alert settings. Pharmacists and pharmacy technicians will gain a deeper understanding of the interoperability between CGMs, automated insulin delivery systems, and other tools, ensuring they can identify ideal candidates for these advanced integrations. By examining best practices for motivational interviewing and clinical follow-up, this panel will provide attendees with practical insights and tips for integrating digital health tools into community practice settings to drive measurable improvements in glycemic outcomes for people living with diabetes.

Target audience: Community pharmacists

Type of activity: Application

Release date: May 22, 2026

Expiration date: May 22, 2027

Learner level: Intermediate, Foundational

Time to complete activity: 1.5 hours

Fee: Free

Educational Objectives

At the completion of this activity, pharmacists will be able to:

• Identify candidates for continuous glucose monitoring (CGM), automated insulin delivery systems, and emerging technologies (including continuous ketone monitoring) based on clinical status and individualized goals
• Analyze CGM data using ambulatory glucose profile reports to guide treatment adjustments and optimize therapeutic outcomes
• Apply interprofessional strategies, including motivational interviewing, data review workflows, and alert-setting best practices, to support people living with diabetes across varied care settings
• Employ evidence-based solutions to overcome clinical, educational, and administrative barriers to technology utilization and long-term persistence